377 related articles for article (PubMed ID: 21656124)
1. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
[TBL] [Abstract][Full Text] [Related]
2. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
[TBL] [Abstract][Full Text] [Related]
3. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Osterweil EK; Krueger DD; Reinhold K; Bear MF
J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
[TBL] [Abstract][Full Text] [Related]
5. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
[TBL] [Abstract][Full Text] [Related]
6. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
[TBL] [Abstract][Full Text] [Related]
7. Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.
Veeraragavan S; Bui N; Perkins JR; Yuva-Paylor LA; Carpenter RL; Paylor R
Psychopharmacology (Berl); 2011 Sep; 217(1):143-51. PubMed ID: 21487657
[TBL] [Abstract][Full Text] [Related]
8. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
[TBL] [Abstract][Full Text] [Related]
9. Rescue of Fmr1
Westmark PR; Dekundy A; Gravius A; Danysz W; Westmark CJ
Neurobiol Dis; 2018 Nov; 119():190-198. PubMed ID: 30125640
[TBL] [Abstract][Full Text] [Related]
10. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.
de Vrij FM; Levenga J; van der Linde HC; Koekkoek SK; De Zeeuw CI; Nelson DL; Oostra BA; Willemsen R
Neurobiol Dis; 2008 Jul; 31(1):127-32. PubMed ID: 18571098
[TBL] [Abstract][Full Text] [Related]
11. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
12. Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.
Pacey LK; Tharmalingam S; Hampson DR
J Pharmacol Exp Ther; 2011 Sep; 338(3):897-905. PubMed ID: 21636656
[TBL] [Abstract][Full Text] [Related]
13. Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).
Veeraragavan S; Graham D; Bui N; Yuva-Paylor LA; Wess J; Paylor R
Behav Brain Res; 2012 Mar; 228(1):1-8. PubMed ID: 22123412
[TBL] [Abstract][Full Text] [Related]
14. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR.
Price TJ; Rashid MH; Millecamps M; Sanoja R; Entrena JM; Cervero F
J Neurosci; 2007 Dec; 27(51):13958-67. PubMed ID: 18094233
[TBL] [Abstract][Full Text] [Related]
15. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
[TBL] [Abstract][Full Text] [Related]
17. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.
Cao Z; Hulsizer S; Tassone F; Tang HT; Hagerman RJ; Rogawski MA; Hagerman PJ; Pessah IN
Hum Mol Genet; 2012 Jul; 21(13):2923-35. PubMed ID: 22466801
[TBL] [Abstract][Full Text] [Related]
18. Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.
Aloisi E; Le Corf K; Dupuis J; Zhang P; Ginger M; Labrousse V; Spatuzza M; Georg Haberl M; Costa L; Shigemoto R; Tappe-Theodor A; Drago F; Vincenzo Piazza P; Mulle C; Groc L; Ciranna L; Catania MV; Frick A
Nat Commun; 2017 Oct; 8(1):1103. PubMed ID: 29062097
[TBL] [Abstract][Full Text] [Related]
19. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
Zhang L; Alger BE
J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
[TBL] [Abstract][Full Text] [Related]
20. Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.
Ding Q; Sethna F; Wang H
Behav Brain Res; 2014 Sep; 271():72-8. PubMed ID: 24886775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
